PLA2G16/HRASLS3 Antibody (OTI1A5) [DyLight 680]

• Reactivity: Hu
• Applications: WB, ICC/IF, IHC
• Clone: OTI1A5
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: DyLight 680

PLA2G16/HRASLS3 Antibody (OTI1A5) [DyLight 680] Summary

• Immunogen: Full length recombinant protein of human PLA2G16/HRASLS3 (NP_009000) produced in HEK293T cells.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Gene: PLA2G16
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry/ Immunofluorescence
  • Immunohistochemistry
  • Immunohistochemistry-Paraffin
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: PBS
• Preservative: 0.05% Sodium Azide
• Purity: Immunogen affinity purified

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for PLA2G16/HRASLS3 Antibody (OTI1A5) [DyLight 680]

• Adipose-specific phospholipase A2
• AdPLA
• AdPLAHRASLS3
• EC 3.1.1.4
• group XVI phospholipase A2
• HRAS-like suppressor 3Ca-independent phospholipase A1/2
• HRASLS3
• HREV107
• H-REV107-1
• HREV107-3adipose-specific PLA2
• HREV107H-rev 107 protein homolog
• MGC118754
• phospholipase A2, group XVI
• PLA2G16
• Renal carcinoma antigen NY-REN-65

Background

Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue. Also has a weak lysophospholipase activity . Tumor suppressor that may be involved in interferon-dependent cell death

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: PLA2G16